I.AytonS
These medications are approved by the Food and Drug Administration (FDA) and are typically prescribed to patients with either a BMI greater than 30 kg/m 2 (obese) or a BMI greater than 27 kg/m 2 with a weight-related comorbidity as adjuncts to lifestyle modifications
The next week I split dosage and administered half a dose twice weekly
Works for injectable GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro, semaglutide, tirzepatide, compounded forms) and oral GLP-1s (Rybelsus, oral Wegovy, Foundayo, orforglipron)
128 MorohakuK.PeltonS
The sweetenerbacteria interactions were tested in two independent experiments, whereby the interactions meeting significance thresholds ( P 90% overlap, 30 out of 33 interactions, Appendix Figs